![AG_assaigCHROMA](http://old.institutmacula.com/wp-content/uploads/AG_assaigCHROMA-300x110.jpg)
· 29/01/2015
CHROMA: Clinical Trial of Lampalizumab for Geographic Atrophy Secondary to Age-Related Macular Degeneration
![Injeccions](http://old.institutmacula.com/wp-content/uploads/Injeccions-300x110.jpg)
· 19/12/2014
FOVISTA NR: Clinical Trial for neovascular age-related macular degeneration
![Lite 1](http://old.institutmacula.com/wp-content/uploads/Lite-1-300x110.jpg)
· 21/12/2014
LITE: Development of Advanced Laser Imaging Techniques for the anterior and posterior Eye
![Foto2](http://old.institutmacula.com/wp-content/uploads/Foto2-300x110.jpg)
· 01/01/2015
FOVISTA: Clinical Trial for subfoveal neovascular age-related macular degeneration
![DMAE atrofica](http://old.institutmacula.com/wp-content/uploads/color-DMAE-atrofica-2-e1364979693690-300x110.jpg)
· 19/03/2014
Clinical trial in antiretroviral-naive patients with choroidal neovascularization secondary to AMD
![Foto4_def](http://old.institutmacula.com/wp-content/uploads/Foto4_def-300x110.jpg)
· 31/03/2014
Phase III Study of Lampalizumab in patients with geographic atrophy secondary to AMD
![Foto44_3](http://old.institutmacula.com/wp-content/uploads/Foto44_3-300x110.jpg)
· 20/12/2014
MPL4 GA: A phase I study in subjects with geographic atrophy secondary to dry age-related macular degeneration
![Foto49_3](http://old.institutmacula.com/wp-content/uploads/Foto49_3-233x110.png)
· 20/12/2014
Oral Omega 3 GA. A phase II in subjects with geographic atrophy secondary to AMD
![color nvc](http://old.institutmacula.com/wp-content/uploads/color-nvc-300x110.png)
· 16/01/2015
A delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration.
![RD edema macular](http://old.institutmacula.com/wp-content/uploads/RD-edema-macular-300x110.jpg)
· 21/12/2014
Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema.
![_MG_8226](http://old.institutmacula.com/wp-content/uploads/MG_8226-300x110.jpg)
· 23/12/2014
Ranibizumab in retinal vein occlusion: treatment recommendations by an expert panel.
![Injeccions (2)](http://old.institutmacula.com/wp-content/uploads/Injeccions-21-300x110.jpg)
· 23/12/2014
Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study.
![LatentClass1](http://old.institutmacula.com/wp-content/uploads/LatentClass1-300x110.jpg)
· 20/11/2014
Reappraisal of geographic atrophy patterns seen on fundus autofluorescence using a latent class analysis approach.
![Glaucoma_Nervioptic1_PORTADA](http://old.institutmacula.com/wp-content/uploads/Glaucoma_Nervioptic1_PORTADA-300x110.jpg)
· 02/07/2014
Prospective, randomised, placebo-controlled, double-masked, three-armed, multicenter Phase II/III trial to establish the safety and efficacy of a topical treatment of Neovascular Glaucoma
![Traccio macular](http://old.institutmacula.com/wp-content/uploads/Traccio-macular-300x110.jpg)
· 02/07/2014
JETREA M-13-056 Assessment of anatomical and functional outcomes in patients treated with ocriplasmin for vitreomacular traction/symptomatic vitreomacular adhesion